+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024 Europe Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis

  • PDF Icon

    Report

  • August 2024
  • Region: Europe
  • VPG Market Research
  • ID: 5994469
This report contains analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report is available by section, and can be customized to specific information needs and budget. The report presents detailed analysis of the STD market in the France, Germany, Italy, Spain, and UK. Current scientific views on epidemiology and etiology are presented for:
  • AIDS/HIV
  • Chancroid
  • Chlamydia
  • Gonorrhea
  • Granuloma Inguinale
  • Herpes I/II
  • Lymphogranuloma
  • Mycoplasma
  • Papillomavirus
  • Syphilis
  • Trichomonas Vaginalis
The report provides test volume and sales forecasts by country and market segment, including:
  • Hospitals
  • Commercial/Private Labs
  • Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies.
  • Reviews features and operating characteristics of major analyzers used for STD testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.